Details for Patent: 10,426,780
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 10,426,780 protect, and when does it expire?
Patent 10,426,780 protects JULUCA and is included in one NDA.
This patent has one hundred and fifteen patent family members in forty-two countries.
Summary for Patent: 10,426,780
| Title: | Antiviral therapy |
| Abstract: | The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC. |
| Inventor(s): | Underwood; Mark Richard (Research Triangle Park, NC) |
| Assignee: | ViiV Healthcare Company (Wilmington, DE) |
| Application Number: | 15/366,442 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,426,780 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; Dosage form; |
Drugs Protected by US Patent 10,426,780
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viiv Hlthcare | JULUCA | dolutegravir sodium; rilpivirine hydrochloride | TABLET;ORAL | 210192-001 | Nov 21, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | Y | TREATMENT OF HIV INFECTION | See Plans and Pricing | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,426,780
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 3551 | See Plans and Pricing | |||
| Australia | 2011209788 | See Plans and Pricing | |||
| Australia | 2014202404 | See Plans and Pricing | |||
| Australia | 2014202405 | See Plans and Pricing | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
